|
|
Name: |
BB BIOTECH AG |
City: |
SCHAFFHAUSEN |
State: |
V8 |
Zip: |
CH8300 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
13 |
|
View All Holdings |
Currently
Viewing:
Unchanged Positions |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
SAGE |
Sage Therapeutics, Inc. |
5 |
- |
$0.00 |
$218,730,000 |
1,375,229 |
5.5% |
86,997,000 |
0 |
2.933 |
N/A |
|
ALXN |
Alexion Pharmaceuticals Inc |
8 |
- |
$182.50 |
$177,684,000 |
1,314,428 |
4.47% |
49,711,000 |
0 |
0.589 |
Drug Manufacturers - ... |
|
HALO |
Halozyme Therapeutics Inc |
12 |
- |
$50.27 |
$133,998,000 |
8,322,860 |
3.37% |
12,235,000 |
0 |
5.849 |
Biotechnology |
|
MRNA |
Moderna, Inc. |
14 |
- |
$0.00 |
$97,389,000 |
4,785,681 |
2.45% |
24,312,000 |
0 |
1.455 |
N/A |
|
MYOV |
Myovant Sciences Ltd. |
15 |
- |
$26.98 |
$85,881,000 |
3,597,882 |
2.16% |
26,840,000 |
0 |
5.913 |
N/A |
|
EXEL |
Exelixis Inc |
19 |
- |
$21.56 |
$67,473,000 |
2,835,000 |
1.7% |
11,709,000 |
0 |
0.959 |
Research Services |
|
WVE |
Wave Life Sciences Ltd. |
23 |
- |
$5.71 |
$56,915,000 |
1,465,002 |
1.43% |
-4,674,000 |
0 |
5.276 |
N/A |
|
VYGR |
Voyager Therapeutics, Inc. |
24 |
- |
$8.16 |
$54,852,000 |
2,865,841 |
1.38% |
27,913,000 |
0 |
8.867 |
N/A |
|
ALDR |
Alder Biopharmaceuticals Inc |
26 |
- |
$18.88 |
$37,756,000 |
2,766,008 |
0.95% |
9,404,000 |
0 |
4.048 |
N/A |
|
ITCI |
Intra Cellular Therapies Inc |
29 |
- |
$75.48 |
$26,796,000 |
2,200,000 |
0.67% |
1,738,000 |
0 |
5.066 |
N/A |
|
GTHX |
G1 Therapeutics Inc |
32 |
- |
$2.56 |
$11,154,000 |
671,925 |
0.28% |
-1,713,000 |
0 |
2.368 |
N/A |
|
CDTX |
Cidara Therapeutics, Inc. |
33 |
- |
$0.00 |
$6,082,000 |
2,295,272 |
0.15% |
688,000 |
0 |
8.292 |
N/A |
|
NVAX |
Novavax Inc |
34 |
- |
$0.36 |
$4,589,000 |
8,330,000 |
0.12% |
-10,738,000 |
0 |
35.492 |
Biotechnology |
|